India · Delayed Price · Currency is INR Symbiotec Pharmalab Company Description
Symbiotec Pharma Lab Pvt. Ltd. develops, manufactures, and markets active pharmaceutical ingredients (APIs), with a primary focus on cortico-steroids and steroid-hormone APIs in both sterile and non-sterile forms.
The company synthesizes progestin, estrone, testosterone, their derivatives, and anabolic steroids, supplying these in commercial volumes globally.
It offers APIs and intermediate pharmaceutical products for therapeutic areas such as gastrointestinal ailments, cardiovascular disease, pain management, paediatrics, anti-infective, and dermatology.
The company provides contract manufacturing (CMO) and contract development and manufacturing (CDMO) services, particularly for fermentation-based APIs, and operates large-scale manufacturing facilities with dedicated research and development and quality control laboratories.
Its product portfolio includes APIs outside the cortico-steroids and hormone categories, with several products under development.
The company serves clients in the pharmaceutical industry, including organizations involved in pharmaceutical manufacturing, contract manufacturing, and research and development, as well as global pharmaceutical companies.
The company was founded in 2002 and is based in Indore, India.
| Country | India |
| Founded | 1995 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 1,752 |
| CEO | Anil Satwani |
Contact Details
Address: 385/2 Pigdamber Indore, 453 331 India | |
| Phone | 91 73 1667 6405 |
| Website | symbiotec.com |
Stock Details
| Ticker Symbol | SYMBIOTEC |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Anil Satwani | Chief Executive Officer |
| Raghavender Ramachandran | Chief Financial Officer |
| Anant Deshpande | Chief Operating Officer |